Preliminary Program

7th. INTERAMERICAN ONCOLOGY CONFERENCE
“Current Status and Future of Anti-Cancer Targeted Therapies”
October 5-6, 2017
Universidad Católica Argentina
Pabellón San José, Juan Pablo II Meeting Room
Puerto Madero, Buenos Aires, Argentina

 

Thursday, October 5th.
09:00 AM – 09:15 AM Opening Remarks
Román Perez Soler
 
New Anticancer Therapies I
Chairpersons: Gabriela Cinat, Gonzalo Recondo
09:15 AM – 09:35 AM Promising Novel Agents in Early Clinical Trials:
Alex A. Adjei, Rochester, USA
09:35 AM – 09:55 AM Defining Predictive Biomarkers for Checkpoint Inhibitors:
Roy Herbst, New Haven, USA
09:55 AM – 10:15 AM Immune Checkpoint Inhibitors for Melanoma:
Antoni Ribas, California, USA
10:15 AM – 10:30 AM Round Table and Questions with Speakers and Chairpersons
10:30 AM – 10:45 AM Break
10:45 AM – 11:45 AM Abbvie Satellite Symposium
11:45 AM – 12:00 PM Coffee Break Sponsored by Abbvie
 
Breast Cancer
Chairpersons: Carlos Bas, Enrique Díaz Cantón
12:00 PM – 12:20 PM New Drugs in Breast Cancer:
Carlos L. Arteaga, Nashville, USA
12:20 PM – 12:40 PM Current Management of HER2+ Breast Cancer:
Carlos L. Arteaga, Nashville, USA
12:40 PM – 12:55 PM Round Table and Questions with Speakers and Chairpersons
12:55 PM – 01:15 PM Lunch Boxes Sponsored by BMS
 
GU Cancer
Chairpersons: Mario Bruno, Enrique Díaz Cantón, Gustavo Jankilevich
01:15 PM – 02:15 PM BMS Satellite Symposium: Is the Immuno-Oncology the New SoC for Renal Cell Carcinoma?
Bernard Escudier, Villejuif, France
02:15 PM – 02:30 PM Break
02:30 PM – 02:50 PM Novel Therapies in Prostate Cancer:
Daniel Petrylak, New Haven, USA
02:50 PM – 03:10 PM The Evolution of Targeted Therapy and Checkpoint Inhibitors in Renal Cancer:
Bernard Escudier, Villejuif, France
03:10 PM – 03:30 PM Advances in the Management of Bladder Cancer:
Daniel Petrylak, New Haven, USA
03:30 PM – 03:45 PM Round Table and Questions with Speakers and Chairpersons
03:45 PM – 04:00 PM Break
 
GI Cancer
Chairpersons: Ricardo Kirchuk, Guillermo Méndez, Juan Manuel O’Connor
04:00 PM – 04:40 PM Lilly Satellite Symposium
04:40 PM – 04:55 PM Coffee Break Sponsored by Lilly
04:55 PM – 05:25 PM New Therapies in the Treatment of Gastric Cancer and Advanced Colorectal Cancer:
Josep Tabernero, Barcelona, Spain
05:25 PM – 05:35 PM Round Table and Questions with Speakers and Chairpersons

 

Adjourn for the day


Friday, October 6th.
09:00 AM – 09:15 AM Opening Remarks
Román Perez Soler
 
New Anticancer Therapies II
Chairpersons: Gonzalo Recondo, Carlos Silva
09:15 AM – 09:35 AM Galectins: Emerging Checkpoints in Immune and Vascular Signaling Programs in Cancer:
Gabriel Rabinovich, Buenos Aires, Argentina
09:35 AM – 09:55 AM An Overview of Immunotherapy in Cancer Treatment:
Antoni Ribas, California, USA
09:55 AM – 10:10 AM Round Table and Questions with Speakers and Chairpersons
10:10 AM – 10:25 AM Break
10:25 AM – 11:25 AM MSD Satellite Symposium: Clinical Evidence and Future Trends in the Immunotherapy of Advanced NSCLC
Roy Herbst, New Haven, USA
11:25 AM – 11:40 AM Coffee Break Sponsored by MSD
 
Lung Cancer
Chairpersons: Claudia Bagnes, Claudio Martin
11:40 AM – 12:40 PM Astra Zeneca Satellite Symposium: Overcoming Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: New Options in Second Line…Moving to First Line?
TBA
12:40 PM – 01:00 PM Lunch Boxes Sponsored by Astra Zeneca
01:00 PM – 01:20 PM Combination Immunotherapy for Lung Cancer:
Scott J. Antonia, Tampa, USA
01:20 PM – 01:40 PM What’s New in the Management of SCLC and Mesothelioma:
Alex A. Adjei, Rochester, USA
01:40 PM – 02:00 PM Current Management of NSCLC:
Román Perez Soler, New York, USA
02:00 PM – 02:15 PM Round Table and Questions with Speakers and Chairpersons
02:15 PM – 02:30 PM Break
 
Hematological Malignancies
Chairpersons: Carolina Pavlovsky, Julio Sánchez Avalos, Marta Zerga
02:30 PM – 03:30 PM BMS Satellite Symposium: The Impact of Immunotherapy in the Treatment of Hodgkin Lymphoma
Stephen Ansell, Rochester, USA
03:30 PM – 03:45 PM Coffee Break Sponsored by BMS
03:45 PM – 04:05 PM New Developments in Lymphoma:
Stephen Ansell, Rochester, USA
04:05 PM – 04:25 PM Novel Drug Development in Leukemia:
Jorge Cortés, Houston, USA
04:25 PM – 04:45 PM Multiple Myeloma:
Kenneth C. Anderson, Boston, USA
04:45 PM – 05:00 PM Round Table and Questions with Speakers and Chairpersons
05:00 PM – 05:10 PM Closing Remarks
Román Perez Soler